Review for "Central nervous system‐infiltrated immune cells induce calcium increase in astrocytes via astroglial purinergic signaling"

Author(s):  
Savina Apolloni
2020 ◽  
Author(s):  
Dunja D. Bijelić ◽  
Katarina D. Milićević ◽  
Milica N. Lazarević ◽  
Djordje M. Miljković ◽  
Jelena J. Bogdanović Pristov ◽  
...  

2020 ◽  
Vol 98 (11) ◽  
pp. 2317-2332
Author(s):  
Dunja D. Bijelić ◽  
Katarina D. Milićević ◽  
Milica N. Lazarević ◽  
Djordje M. Miljković ◽  
Jelena J. Bogdanović Pristov ◽  
...  

2021 ◽  
pp. 107385842199226
Author(s):  
Stellina Y. H. Lee ◽  
Nathanael J. Yates ◽  
Susannah J. Tye

Inflammation is a critical factor contributing to the progressive neurodegenerative process observed in Parkinson’s disease (PD). Microglia, the immune cells of the central nervous system, are activated early in PD pathogenesis and can both trigger and propagate early disease processes via innate and adaptive immune mechanisms such as upregulated immune cells and antibody-mediated inflammation. Downstream cytokines and gene regulators such as microRNA (miRNA) coordinate later disease course and mediate disease progression. Biomarkers signifying the inflammatory and neurodegenerative processes at play within the central nervous system are of increasing interest to clinical teams. To be effective, such biomarkers must achieve the highest sensitivity and specificity for predicting PD risk, confirming diagnosis, or monitoring disease severity. The aim of this review was to summarize the current preclinical and clinical evidence that suggests that inflammatory processes contribute to the initiation and progression of neurodegenerative processes in PD. In this article, we further summarize the data about main inflammatory biomarkers described in PD to date and their potential for regulation as a novel target for disease-modifying pharmacological strategies.


2018 ◽  
Vol 25 (3) ◽  
pp. 227-240 ◽  
Author(s):  
Mithilesh Kumar Jha ◽  
Myungjin Jo ◽  
Jae-Hong Kim ◽  
Kyoungho Suk

Microglia-astrocyte crosstalk has recently been at the forefront of glial research. Emerging evidence illustrates that microglia- and astrocyte-derived signals are the functional determinants for the fates of astrocytes and microglia, respectively. By releasing diverse signaling molecules, both microglia and astrocytes establish autocrine feedback and their bidirectional conversation for a tight reciprocal modulation during central nervous system (CNS) insult or injury. Microglia, the constant sensors of changes in the CNS microenvironment and restorers of tissue homeostasis, not only serve as the primary immune cells of the CNS but also regulate the innate immune functions of astrocytes. Similarly, microglia determine the functions of reactive astrocytes, ranging from neuroprotective to neurotoxic. Conversely, astrocytes through their secreted molecules regulate microglial phenotypes and functions ranging from motility to phagocytosis. Altogether, the microglia-astrocyte crosstalk is fundamental to neuronal functions and dysfunctions. This review discusses the current understanding of the intimate molecular conversation between microglia and astrocytes and outlines its potential implications in CNS health and disease.


Sign in / Sign up

Export Citation Format

Share Document